# Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

> **NCT05840861** · — · UNKNOWN · sponsor: **Central South University** · enrollment: 59 (estimated)

## Conditions studied

- Major Depressive Disorder
- Bipolar Disorder

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT05840861
- **Lead sponsor:** Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-05
- **Primary completion:** 2023-08-21
- **Final completion:** 2023-09-05
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2023-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840861, "Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05840861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*